No Data
No Data
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
Mizuho Securities Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Scotiabank Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $3.15
Scotiabank Remains a Buy on Adaptimmune Therapeutics (ADAP)
No Data